results found
This chart collection takes a look at how spending on healthcare in the United States compares to other OECD countries that are similarly large and wealthy (based on GDP and GDP per capita). The analysis looks at 2017 health data …
Prescription drug spending grew rapidly between 2014 and 2015, but increases have been more modest recently. Several studies by the federal government, pharmacy benefit managers, and insurers point to high prices for new “specialty” drugs as driving the spike, in …
Total health spending is a function of both price paid to providers or for drugs and the volume of services used. These charts explore prices and use of health services in the U.S. relative to comparable countries (those with both …
In this analysis, we explore trends in prices for health services over time in the U.S. (A related chart collection shows trends in prices and utilization in the U.S. and comparable countries). We find that prices have increased for a …
With deaths from opioid overdose rising steeply in recent years, and a large segment of the population reporting knowing someone who has been addicted to prescription painkillers, the breadth of the opioid crisis should come as no surprise, affecting people …
This collection of charts complements our brief, “A look at how the opioid crisis has affected people with employer coverage,” which uses claims data from large employers to examine how the opioid crisis has affected people with large employer coverage, …
This chart collection explores the distribution of out-of-pocket spending among people with large employer coverage using the Truven Health Analytics MarketScan Commercial Claims and Encounters Database. We examine trends in out-of-pocket spending by people with employer coverage from 2005 to …
As deductibles in health insurance plans have grown, there is concern about the level of out-of-pocket health costs faced by workers and their families with health insurance. In this brief, we present new analysis of the share of people with …
This collection of charts (updated July 31, 2017) explores trends in the prevalence, outcomes, costs, and access to care associated with mental health and substance use disorders in the United States and comparably wealthy countries. A related brief offers discussion …
This collection of charts and a related brief explore trends in the costs of treating diseases. The Bureau of Economic Analysis (BEA) disease-based health spending estimates allows users to examine national health spending trends by disease category from 2000 – …